Antihypertensive therapy of bevacizumab-induced hypertension.
Not Applicable
- Conditions
- Hypertension
- Registration Number
- JPRN-UMIN000019287
- Lead Sponsor
- Shizuoka Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Not provided
Exclusion Criteria
1)Renal failure (Cre>=1.5mg/dL)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method